for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

Dr Reddy's loses bid to invalidate Horizon arthritis drug patents

Indian generic drugmaker Dr Reddy’s Laboratories Ltd has lost a bid to invalidate patents on Horizon Therapeutics Plc and Nuvo Pharmaceuticals Inc’s arthritis drug Vimovo.

U.S. District Judge Stanley Chesler in New Jersey on Wednesday rejected Dr Reddy’s argument that the Federal Circuit had already effectively resolved the issue by invalidating two similar patents in 2019.

To read the full story on Westlaw Today, click here: bit.ly/3k24CV8

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up